AeroLeads people directory · profile
Neil Bell Email & Phone Number
Managing Director
at
Bell Partners Ltd
1 work email found
@avacta.com
1 phone found area 203
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Managing Director
Location
United Kingdom, United Kingdom, United Kingdom
Company size
Who is Neil Bell? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Neil Bell is listed as Managing Director at Bell Partners Ltd, a company with 1 employees, based in United Kingdom, United Kingdom, United Kingdom. AeroLeads shows a work email signal at avacta.com, phone signal with area code 203, and a matched LinkedIn profile for Neil Bell.
Neil Bell previously worked as Independent Consultant at Bell Partners Ltd and Chief Development Officer (CDO) at Avacta. Neil Bell holds Master Of Science - Msc, Radiation Biophysics from University Of St Andrews.
Company email context
Email format at Bell Partners Ltd
This section adds company-level context without repeating Neil Bell's masked contact details.
{first}.{last}@avacta.com
86% confidence
AeroLeads found 1 current-domain work email signal for Neil Bell. Compare company email patterns before reaching out.
Profile bio
About Neil Bell
Neil Bell is a Managing Director at Bell Partners Ltd. He possess expertise in clinical trials, respiration, cro, gastroenterology, neurology and 16 more skills.
Listed skills include Clinical Trials, Respiration, Cro, Gastroenterology, and 17 others.
Current workplace
Neil Bell's current company
Company context helps verify the profile and gives searchers a useful next step.
Bell Partners Ltd
11 roles · 41 years
Neil Bell work experience
A career timeline built from the work history available for this profile.
Independent Consultant
CurrentFocused on helping Life Science companies achieve their potential
2019 - Present
~7 yrs 4 mos
Chief Development Officer (Cdo)
Publicly-listed (AIM) clinical-stage biotech specialising in early development of multiple oncology assets from research through to clinic using in-house platformsSpearheaded strategic direction and development of Avacta’s lead FAP-activated development candidate AVA6000 & transformed Avacta into a clinical stage biotech.
Jul 2020 - Dec 2023
Senior Vice President, Head Of Global Development Operations For Car-T Programmes
NASDAQ-listed CAR-T biotech developing advanced autologous therapies for cancer patients using reprogrammed T cells (harvested, reprogrammed and returned to the donor patient)Initiated first CAR-T cell clinical trial programmes in Europe & US for Autolus
Apr 2016 - Dec 2019
Executive Director, Head Of Clinical Development Operations
Japanese headquartered pharmaceutical development company focused on early and late development of in-house and licensed assets across oncology & cardiovascular therapy areas
2012 - 2016
~4 yrs
Head Of Global Development Operations & Project Management
Global pharmaceutical innovative R&D group located across three regions (US, Europe and Japan) focused on joint development of respiratory, neurodegenerative & oncology therapy areas
2004 - 2012
~8 yrs
Therapeutic Area Head, Gastroenterology & Neurology
A mid-sized biopharmaceutical company with deep expertise in peptide technology and small molecules from discovery through to clinic and focused on bringing transformative therapies in oncology, rare disease and neuroscience to patients
1999 - 2004
~5 yrs
Clinical Project Manager, Darifenacin Development Team
Global R&D covering early research and clinical development assets (Phase I, 2 & 3)
1997 - 1999
~2 yrs
Clinical Project Leader, Pariet Development Team
Japanese headquartered global R&D (based in US, Europe & Japan) mainly focused on neurology and gastroenterology. Eisai achieved two successful marketing approvals during tenure (Aricept & Pariet).
1989 - 1997
~8 yrs
Clinical Research Associate, Phase 1, 2 & 3 Clinical Research - Inflammatory Disease
1987 - 1989
~2 yrs
Research Associate – Bone Marrow Transplant Team (T-Cell Depletion Programme)
Royal Free Medical School, London
1985 - 1987
~2 yrs
2 education records
Neil Bell education
Master Of Science - Msc, Radiation Biophysics
University Of St Andrews
Bachelor Of Science - Bsc, Genetics
University Of Liverpool
FAQ
Frequently asked questions about Neil Bell
Quick answers generated from the profile data available on this page.
What company does Neil Bell work for?
Neil Bell works for Bell Partners Ltd.
What is Neil Bell's role at Bell Partners Ltd?
Neil Bell is listed as Managing Director at Bell Partners Ltd.
What is Neil Bell's email address?
AeroLeads has found 1 work email signal at @avacta.com for Neil Bell at Bell Partners Ltd.
What is Neil Bell's phone number?
AeroLeads has found 1 phone signal(s) with area code 203 for Neil Bell at Bell Partners Ltd.
Where is Neil Bell based?
Neil Bell is based in United Kingdom, United Kingdom, United Kingdom while working with Bell Partners Ltd.
What companies has Neil Bell worked for?
Neil Bell has worked for Bell Partners Ltd, Avacta, Autolus Therapeutics, Daiichi Sankyo Europe Gmbh, and Teva Pharmaceuticals.
How can I contact Neil Bell?
You can use AeroLeads to view verified contact signals for Neil Bell at Bell Partners Ltd, including work email, phone, and LinkedIn data when available.
What schools did Neil Bell attend?
Neil Bell holds Master Of Science - Msc, Radiation Biophysics from University Of St Andrews.
What skills is Neil Bell known for?
Neil Bell is listed with skills including Clinical Trials, Respiration, Cro, Gastroenterology, Neurology, Clinical Research, Ctms, and Biotechnology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial